Ananya Sen
Sen covers cancer clinical care and pediatric cancer research, ophthalmology, endocrinology, diabetes, emergency medicine, survival flight, and children's and women's health. Sen completed her Ph.D. in Microbiology from the University of Illinois Urbana-Champaign where she then worked as a science writer after graduation.
Health Lab
Interplay between key proteins could serve as a target for cancer treatment
University of Michigan researchers have identified that the balance between two proteins—STAT3 and STAT5—is important for making tumors vulnerable to immune checkpoint therapy, and targeting STAT3 degradation is a potential novel cancer immunotherapy strategy.
Health Lab
Researchers identify roles of key genes in colon cancer development
Researchers used mouse models and studies of colorectal cancer tissues to show that loss of SOX9 gene promotes tumor progression and the pathway it regulates can be a potential target for future treatments.
Health Lab
More men with prostate cancer are avoiding unnecessary surgery
Researchers at University of Michigan showed that the proportion of patients undergoing prostatectomy for the lowest risk type of cancer dropped over fivefold between 2010 to 2024.
Health Lab
Drug combination reduces breast cancer risk and improves metabolic health in rats
Researchers investigated the combined effects of bazedoxifene and conjugated estrogens in rat models as an alternative to tamoxifen.
Health Lab
Drug targets identified for pancreatic cancer
U-M researchers have discovered that simultaneously targeting PIKfyve and KRAS-MAPK can eliminate tumors in preclinical human and mouse models.
Health Lab
Researchers use nanoparticles to target glioblastoma in mice
University of Michigan researchers have created nanodiscs that can target cholesterol levels in GBM, starving the cancer cells and increasing survival rates of the treated mice.
Health Lab
For eye infections, delayed doctor visits and extent of damage affect vision outcomes
Physicians followed 562 patients in the U.S. and India over a three-month period to identify risk factors for eye infections that could be easily managed with early intervention.
Health Lab
Regular eye drop regimens are crucial for glaucoma patients
Paula Anne Newman-Casey, M.D., discusses the causes of glaucoma, how it’s diagnosed, treatment procedures and why many people miss doses of their medicated eye drops.
Health Lab
‘Beating the odds’: hope for U-M drummer with inoperable brain tumor
Ethan White was diagnosed with diffuse midline glioma, a rare form of brain cancer where the survival time after diagnosis is 1-2 years. His treatment is going well and Koschmann is cautiously optimistic about his case.
Health Lab
After prostate cancer surgery, 70-year-old track and field athlete takes on international competition
Just 8 months after undergoing robotic surgery to remove his cancerous prostate, Mark Cwiek, a 70-year-old track and field athlete, successfully competed in the World Masters Athletics Championship.
Health Lab
Personalized app reduces cancer-related fatigue
Researchers at the Rogel Cancer Center, in collaboration with Arcascope, have developed and tested a personalized app that tracks a user’s circadian rhythm and makes behavioral recommendations to reduce daily fatigue.
Health Lab
Continuous glucose monitors can optimize diabetic ketoacidosis management
University of Michigan researchers show that using continuous glucose monitors can help measure glucose accurately during DKA and potentially prevent ICUs from being overwhelmed.
Health Lab
New cellular therapy trials for brain tumors
Michigan Medicine experts discuss CAR T therapy, its use in other clinical trials at U-M and the new Phase I trials that started in March 2025.
Health Lab
How to assess your risk for breast cancer
Melissa Pilewskie, M.D., answers questions about how you can accurately assess your risk and what lifestyle changes can help reduce the likelihood of developing breast cancer.
Health Lab
Managing your diabetes can help prevent associated vision loss
Diabetic retinal disease screening remains challenging because patients often do not have any symptoms in the early stages and, therefore, misunderstand the importance of regular screenings. In a recent publication Thomas Gardner discusses current screening recommendations and treatment options for DRD.
